The biology of brain metastases: Experimental therapy approaches;Die biologie von hirnmetastasen: Experimentelle therapieansatze

Onkologe

Volumn 6, Issue 10, 2000, Pages 976-985

  Schackert, G ^a   Fidler, I J ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

BRAIN METASTASIS; METASTASIS; REVIEW; SURGICAL ANATOMY;

EID: 0033766534     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007610070043     Document Type: Review

References (57)

1. Metastatic distribution in malignant melanoma. A 30-year autopsy study
2. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD 44
3. Development of a metastatic brain tumor model in mice
4. B-cell stimulatory factor 1 (interleukin-4) activates macrophages for increased tumoricidal activity and expression of 1a antigens
5. Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-β
6. Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene
7. The blood-brain barrier redefined
8. 1251-5-iodo- 2'-deoxyuridine
9. Selection of successive tumor lines for metastasis
10. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis
11. Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines
12. Macrophages and metastasis - A biological approach to cancer therapy: Presidential address
13. The biology of cancer metastasis and implications for therapy
14. Localization and actions of transforming growth factor-β in the embryonic nervous system
15. Critical factors regulating site-specific brain metastasis of routine melanomas
16. Selective growth of human melanoma cells in the brain parenchyma of nude mice
17. The role for transforming growth factor-beta (TGF-beta) in human cancer
18. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
19. Growth factors and cancer
20. Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat
21. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma
22. Cell adhesion receptor expression during melanoma progression and metastasis
23. CD44 - A molecule involved in leukocyte adherence and T-cell activation
24. The physiology of the blood-brain barrier
25. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF.7 human breast cancer cells grown in the short-term and long-term absence of estrogens
26. Clinical management of recurrent hepatocellular carcinoma after primary resection
27. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage of metastatic cancer: Malignant melanoma as a paradigm
28. Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains
29. Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse
30. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites
31. Differences between the peripheral and the central nervous system in permeability to sodium fluorescein
32. Interleukin-4 (B-cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells
33. Heparan sulfate degradation: Relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines
34. Organ specificity of tumor metastasis: Role of preferential adhesion, invasion, and growth of malignant cells at specific secondary sites
35. Ten years disease-free survival after solitary brain metastasis from breast cancer
36. Brain metastases. Histology, multiplicity, surgery, and survival
37. Brain metastases
38. Management of brain metastases
39. The pathogenesis of cancer metastasis
40. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements
41. Development of in vivo models for studies of brain metastasis
42. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or the meninges of syngeneic animals
43. Regional growth of different human melanomas as metastases in the brain of nude mice
44. Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice
45. Macrophage infiltration into experimental brain metastases: Occurrence through in intact blood-brain barrier
46. Arrest and retention of multilamellar liposomes in the brain of normzal mice or mice bearing experimental brain metastases
47. Systemic immunity against a routine colon tumor (CT-26) produced by immunization with syngeneic cells expressing a transfected viral gene product
48. Is the brain an immunological privileged site?
49. Principles of brain tumor chemotherapy
50. Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect
51. Theory and practice of sitespecific drug delivery
52. Local expression of murine IL-4 by tumor cells as a potential tool in the immunotherapy of brain metastases
53. Immuntherapie von Hirnmetastasen mit xenogenisierten Tumorzellen, die transfizierte Zytokin- und virale Genprodukte exprimieren
54. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis
55. Differential permeability of the bloodbrain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice